HAUS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.390800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.852400E-01
Normal-vs-Stage2
8.991600E-01
Normal-vs-Stage3
8.570000E-02
Normal-vs-Stage4
3.197000E-01
Stage1-vs-Stage2
6.336000E-01
Stage1-vs-Stage3
1.707970E-02
Stage1-vs-Stage4
1.838180E-01
Stage2-vs-Stage3
5.840300E-02
Stage2-vs-Stage4
5.928000E-01
Stage3-vs-Stage4
2.217700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.075200E-01
Normal-vs-AfricanAmerican
9.470200E-01
Normal-vs-Asian
5.113600E-01
Caucasian-vs-AfricanAmerican
9.483600E-01
Caucasian-vs-Asian
1.227760E-01
AfricanAmerican-vs-Asian
3.843200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.704600E-01
Normal-vs-Female
8.185400E-01
Male-vs-Female
3.232600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.043200E-01
Normal-vs-Age(41-60Yrs)
5.023200E-01
Normal-vs-Age(61-80Yrs)
8.890800E-01
Normal-vs-Age(81-100Yrs)
5.330000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.058000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.901200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.965600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.052290E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.036200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.456600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.899200E-01
Normal-vs-Daily Drinker
9.014200E-01
Normal-vs-Weekly Drinker
9.461400E-01
Normal-vs-Occasional Drinker
7.271600E-01
Normal-vs-Social Drinker
9.475200E-01
Non Drinker-vs-Daily Drinker
7.810000E-01
Non Drinker-vs-Weekly Drinker
5.525400E-01
Non Drinker-vs-Occasional Drinker
2.522800E-01
Non Drinker-vs-Social Drinker
5.266800E-01
Daily Drinker-vs-Weekly Drinker
7.401800E-01
Daily Drinker-vs-Occasional Drinker
4.241800E-01
Daily Drinker-vs-Social Drinker
7.349000E-01
Weekly Drinker-vs-Occasional Drinker
7.395000E-01
Weekly Drinker-vs-Social Drinker
9.632400E-01
Occasional Drinker-vs-Social Drinker
6.275600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.083000E-01
Normal-vs-Grade 2
5.513000E-01
Normal-vs-Grade 3
5.586000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.314430E-02
Grade 1-vs-Grade 3
3.821900E-02
Grade 1-vs-Grade 4
3.083000E-01
Grade 2-vs-Grade 3
8.666600E-01
Grade 2-vs-Grade 4
5.513000E-01
Grade 3-vs-Grade 4
5.586000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.173000E-01
Normal-vs-NonDiabetic
9.275400E-01
Diabetic-vs-NonDiabetic
1.481040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.075200E-01
Normal-vs-NoPancreatitis
9.530600E-01
Pancreatitis-vs-NoPancreatitis
6.630800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.899600E-01
Normal-vs-N1
8.527600E-01
N0-vs-N1
2.816000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.533000E-01
Normal-vs-TP53-NonMutant
9.422200E-01
TP53-Mutant-vs-TP53-NonMutant
3.512500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
